Stockreport

ZyVersa Therapeutics Reports Third Quarter 2025 Financial Results

ZyVersa Therapeutics, Inc.  (ZVSA) 
PDF ZyVersa is advancing a therapeutic development pipeline with multiple programs built around its two proprietary technologies – Cholesterol Efflux Mediator VAR 200 for tr [Read more]